WHAT: Cancer Center Council 16th Annual Spring Luncheon. Proceeds benefit the Patient Assistance Fund of the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio.
WHEN: Tuesday, March 17, 11:30 a.m.
WHERE: Pearl Stable, 312 Pearl Parkway
WHO: Keynote speaker: Kris Carr, an award-winning actress, best-selling author, filmmaker and subject of the uplifting documentary Crazy, Sexy Cancer. She wrote and directed the film, which chronicles her four-year adventure of living and thriving with stage-four cancer. It premiered at the South by Southwest Film Festival and was broadcast on The Learning Channel and Discovery Health in 2007.
Other credits:
• Crazy, Sexy Cancer Tips—Carr’s first book, with a foreword by singer/songwriter Sheryl Crow, was translated into six languages within the first year of print.
• Crazy, Sexy Cancer Survivor: More Rebellion and Fire for Your Healing Journey—Carr’s second book was released in 2008.
• Crazysexylife.com—Carr’s blog and social network.
• Featured on numerous national television programs, including the CBS Evening News with Katie Couric, The Early Show, Today Show, Good Morning America and The Oprah Winfrey Show.
Reporters are invited for lunch. Please RSVP by March 12 to Varonica McKinney, 450-5571.
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the nation’s leading academic research and treatment centers, serving more than 4.4 million people in the high-growth corridor of Central and South Texas including Austin, San Antonio, Laredo and the Rio Grande Valley. CTRC is one of a few elite cancer centers in the country to be named a National Cancer Institute (NCI)-Designated Cancer Center, and is one of only three in Texas. CTRC handles more than 120,000 patient visits each year and is a world leader in developing new drugs to treat cancer. The CTRC Institute for Drug Development (IDD) is internationally recognized for conducting the largest oncology Phase I clinical drug studies program in the world. IDD has participated in the clinical and/or preclinical development of many of the cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit http://ctrc.uthscsa.edu.